Qube Research & Technologies (QRT)
EPIX

Qube Research & Technologies (QRT)’s ESSA Pharma EPIX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,353
Closed -$36K – 2626
2022
Q2 		$36K Sell
11,353
-36,302
-76% -$203K ﹤0.01% 2183
2022
Q1 		$295K Buy
+47,655
New +$419K ﹤0.01% 1792

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EPIX Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 11,353 shares — an estimated $36K sold.

Qube Research & Technologies (QRT) first reported a position in EPIX in Q1 2022 and held it in 2 quarters. The position peaked at $295K in Q1 2022. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11,353 ESSA Pharma shares in Q3 2022, an estimated $36K.
  • Qube Research & Technologies (QRT) first reported a position in ESSA Pharma in Q1 2022 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s ESSA Pharma position peaked at $295K in Q1 2022.
  • 54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.